Developer docs
API playgroundTry for free, no card

Search company profiles

Latinaba

Full company profile

uuid000w2wj

Namestring
Latinaba
Legal namestring
LatinaBA
Websiteurl
latinaba.com
Company typeenum
Private
Founded yearint
2009
Descriptiontext

Latinaba (operating as LatinaBA or LBA) is a privately held Contract Research Organization founded in 2009 and headquartered in Buenos Aires, Argentina, with business development offices in Coral Gables, Florida, and country operations offices in Brazil and Chile. The company delivers clinical research services to pharmaceutical and biotech sponsors conducting trials across 15 Latin American countries, operating with a headcount of 11-50 employees. Latinaba provides end-to-end clinical trial execution across Phase I-IV studies, covering site identification and monitoring, regulatory affairs, safety surveillance, medical writing, and trial oversight, with experience spanning 35 therapeutic areas including vaccines, infectious diseases, oncology, cardiovascular, and neurology. Since inception, the company has reported 135 completed projects served across 93 distinct sponsors.

The company's service portfolio is organized into core modules covering Clinical Operations & Project Management, Regulatory Affairs, Medical Devices Research, Real World Evidence studies, Medical Scientific Services, MSL Services, Clinical Trial Oversight, Resourcing Services (including a rent-a-monitor program), CRO and Sponsor Oversight, Quality Programs and Dedicated Services, and Consulting. Latinaba holds ISO certification, signals compliance with ICH-GCP and local regulatory requirements, and combines clinical and epidemiological trial capabilities. Leadership includes CEO Mariano Zarzecki (joined 2016 as COO, became CEO), CFO Cecilia Vidart (joined 2010), Country Manager Brazil Joyce Marinho (founding member of acquired Medicamenta), and Country Manager Chile Alejandro Bisquertt Zavala.

Latinaba generates revenue through professional services contracts on a quote-based pricing model tailored to individual study scope, phase, and geographic coverage. The company distributes services via direct enterprise field sales targeting pharma and biotech sponsors, supported by a US-based business development office and a LinkedIn corporate presence. The 2013 acquisition of Brazilian CRO Medicamenta established Brazil operations, and in January 2025 Latinaba entered a strategic partnership with Belgian CRO P95 BV to enhance vaccine and infectious disease trial capabilities and extend geographic reach across Latin America.

Short descriptiontext

Latinaba is a private Contract Research Organization founded in 2009 that provides clinical trial services—including site management, regulatory affairs, monitoring, and medical writing—to pharmaceutical and biotech sponsors across 15 Latin American countries.

Operating statusenum
Operating
Ownership categoryenum
Headcount rangeband
11–50
akta.pro rankint
HeadquartersCoral Gables, United States
HQ citystring
Coral Gables
HQ countrystring
United States
HQ regionstring
North America
Markets served

Serves global market

Offices4 records

Each record includes

City, Country, Type, Description, Source

Keyword5 values
contract research organization, clinical trial services, clinical research operations, regulatory affairs services, real world evidence research
Industry3 codes
PRIMARYHLAGAAAA
Clinical CROs (Phase I–IV)
SECONDARYHLAGACAE
Clinical Trial Site Operations & Study Coordination
SECONDARYHLAGAAAG
Medical Writing & Regulatory Submission Support CROs
NAICS code1 code
  • Research and Development in the Physical, Engineering, and Life Sciences54171
SIC code1 code
  • Services-Commercial Physical & Biological Research8731
Product category
Contract Research Organization Services
Social media profiles1 record
GTM motion1 record

Each record includes

Type, Description, Source

Revenue model1 record
1Clinical Research Services
TypeProfessional Services
Description

Latinaba generates revenue by providing contract clinical research services to pharmaceutical and biotech sponsors. Services include clinical operations, project management, regulatory affairs, site identification, monitoring, safety surveillance, medical writing, and trial oversight across all phases of clinical development.

latinaba.com
Marketing channels1 record

Each record includes

Title, Type, Stage, Description, Source

Distribution channels1 record

Each record includes

Title, Type, Scope, Target buyer, Description, Source

Cost components5 values
Personnel, Operations, Marketing or Sales, Technology or R&D, Infrastructure
GTM typeB2B
B2B
Offering typeServices
Services
Core offering1 text field

Latinaba is a regional Contract Research Organization (CRO) that provides contract clinical research services to pharmaceutical and biotech sponsors conducting trials in Latin America. Its offerings span clinical operations and project management, site identification, regulatory affairs, monitoring, safety surveillance, medical writing, real-world evidence studies, MSL services, and trial oversight, covering Phase I-IV studies and pharmacokinetics across 15 countries.

Differentiator
Functional benefit
Problem solved
Quantifiable outcome1 of 3 values shown
  • 135 completed projects delivered successfully
+2 more records
Product overview1 text field

Latinaba is a regional Contract Research Organization (CRO) offering a unified suite of clinical research services for pharmaceutical and biotech sponsors conducting trials in Latin America. The company operates through an integrated platform of service modules that span the full clinical development lifecycle: Clinical Operations & Project Management, Regulatory Affairs, Medical Devices Research, Real World Evidence (RWE) Studies, Medical Scientific Services, MSL Services, Clinical Trial Oversight, Resourcing Services, CRO and Sponsor Oversight, Quality Programs & Dedicated Services, and Consulting. With over 16 years of market experience and offices in Argentina (headquarters), Brazil, and Chile, Latinaba delivers end-to-end clinical trial execution across Phase I to IV studies. The company has completed 135 projects across 15 countries and 93 different sponsors, with expertise spanning 35 therapeutic areas including vaccines, infectious diseases, oncology, cardiovascular, and rare diseases. Recently, Latinaba entered a strategic partnership with P95 BV to enhance vaccine research capabilities in the region.

Product and service11 records
1Clinical Operations & Project Management
CategoryClinical Research Operations
2Regulatory Affairs
CategoryRegulatory Services
3Medical Devices Research
CategoryClinical Research Operations
4Real World Evidence
CategoryReal World Evidence Research
5Medical Scientific Services
CategoryMedical and Scientific Services
6MSL Services
CategoryMedical and Scientific Services
7Clinical Trial Oversight
CategoryClinical Trial Oversight
8Resourcing Services
CategoryResourcing and Training
9CRO and Sponsor Oversight
CategoryClinical Trial Oversight
10Quality Programs & Dedicated Services
CategoryQuality Assurance
11Consulting
CategoryConsulting
Scale indicator5 records

Each record includes

Type, Value, Description, Source

Partnership1 partner
Strategic tierCoreTypeStrategic or Co-development PartnerAnnounced on2025-01-29
Description

P95 BV, a Belgian full-service CRO specializing in vaccine development and infectious diseases, has entered a strategic partnership with LatinaBA. The collaboration combines both organizations' strengths to enhance the execution of clinical and epidemiological trials across Latin America, extending their reach to additional countries. Both companies' CEOs highlighted the complementary expertise that will enable better service to vaccine manufacturers and expanded treatment options for patients in Latin America.

Recent move5 records

Each record includes

Date, Type, Title, Description, Source

Expansion highlight4 records

Each record includes

Type, Description

Peers10 records
TypeDirect peer
Description

Mid-sized global CRO with therapeutic-area specialization and central lab capabilities; comparable in scale and service scope to LatinaBA and a competitor for mid-sized LATAM clinical studies.

2GEMATEC (Argentina)
TypeRegional player
Description

Regional Argentine CRO providing clinical trial management services in Latin America; closely comparable to LatinaBA as a domestic LATAM regional player competing for the same sponsor mandates.

TypeDirect peer
Description

Belgian full-service CRO specializing in vaccine development and infectious diseases; signed a strategic alliance with LatinaBA in January 2025 to jointly deliver vaccine and epidemiological trials in Latin America — direct peer in clinical trial execution for vaccine sponsors.

TypeBroad incumbent
Description

Provides preclinical and clinical CRO services globally; competes with LatinaBA in the early-phase and clinical research services market and has established LATAM client relationships.

TypeDirect peer
Description

Mid-sized global full-service CRO with strong therapeutic-area depth across Phase I–IV studies; comparable to LatinaBA's full-service clinical operations model, though at vastly greater scale and geographic reach.

TypeBroad incumbent
Description

Largest global CRO with significant LATAM presence, real-world evidence, and technology-enabled trial services; competes head-to-head with LatinaBA for multinational and regional pharma sponsors seeking LATAM execution.

TypeBroad incumbent
Description

Global CRO providing clinical research, laboratory, and post-approval services; competes with LatinaBA for LATAM clinical trial work and offers overlapping therapeutic-area coverage and regulatory expertise at a larger scale.

TypeDirect peer
Description

Biopharma solutions organization offering clinical and commercial services globally, including LATAM; comparable full-service clinical operations model across multiple therapeutic areas.

TypeBroad incumbent
Description

Global CRO acquired by Thermo Fisher in 2021; provides comprehensive clinical development and laboratory services with established LATAM capabilities, directly competing with LatinaBA for regional trial mandates.

TypeBroad incumbent
Description

Global CRO offering Phase I–IV clinical services, regulatory consulting, and post-approval evidence; directly competes with LatinaBA on LATAM-based clinical trial execution and biopharma sponsor RFPs.

Market position
Strengths4 records

Each record includes

Headline, Details, Source

Weaknesses4 records

Each record includes

Headline, Details, Source

Competitive moat4 records

Each record includes

Type, Details

Key risks6 records

Each record includes

Headline, Details, Source

Key highlights7 records

Each record includes

Headline, Details, Source

Customer concentration

Classification, Details

Segment1 record

Each record includes

Title, Type, Primary, Description, Pain point addressed, Use case, Source

Ideal customer profile1 record

Each record includes

Profile, Firmographic size, Sales motion, Sales cycle length, Buying structure, Purchase trigger, Buyer persona, Geography, Industry vertical, Primary use case, Description, Pain points, Evidence proof points, Target buyer

Technology focused
No
API detail
Has APIbool
No

Docs URL, Description

AI maturity
App detail

Has app

Core technology
Revenue estimate
Valuation estimate
Number of profiles
Profiles4 records

Each record includes

Name, Designation, Designation category, Overview, Profile commentary, Source

Subsidiaries1 record

Each record includes

Name, Acquired on, Relationship type, Type, Business focus

Compliance1 record

Each record includes

Name, Class, Description

Funding overview

Funding stage, Last funding date, Total funding USD

Funding rounds

Each record includes

Round, Amount USD, Date, Pre money valuation, Total investors, Investors, News

Investors

Each record includes

Name, Type, Date of entry, Rounds participated, Website

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Each record includes

Name, Acquisition type, Announced date, Completed date, Status, Website, News

Investment

Each record includes

Name, Round, Announced date, Lead investor, Website, News

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Latinaba

Contract Research Organization Serviceslatinaba.com

Latinaba is a private Contract Research Organization founded in 2009 that provides clinical trial services—including site management, regulatory affairs, monitoring, and medical writing—to pharmaceutical and biotech sponsors across 15 Latin American countries.

What Latinaba does

Latinaba (operating as LatinaBA or LBA) is a privately held Contract Research Organization founded in 2009 and headquartered in Buenos Aires, Argentina, with business development offices in Coral Gables, Florida, and country operations offices in Brazil and Chile. The company delivers clinical research services to pharmaceutical and biotech sponsors conducting trials across 15 Latin American countries, operating with a headcount of 11-50 employees. Latinaba provides end-to-end clinical trial execution across Phase I-IV studies, covering site identification and monitoring, regulatory affairs, safety surveillance, medical writing, and trial oversight, with experience spanning 35 therapeutic areas including vaccines, infectious diseases, oncology, cardiovascular, and neurology. Since inception, the company has reported 135 completed projects served across 93 distinct sponsors.

The company's service portfolio is organized into core modules covering Clinical Operations & Project Management, Regulatory Affairs, Medical Devices Research, Real World Evidence studies, Medical Scientific Services, MSL Services, Clinical Trial Oversight, Resourcing Services (including a rent-a-monitor program), CRO and Sponsor Oversight, Quality Programs and Dedicated Services, and Consulting. Latinaba holds ISO certification, signals compliance with ICH-GCP and local regulatory requirements, and combines clinical and epidemiological trial capabilities. Leadership includes CEO Mariano Zarzecki (joined 2016 as COO, became CEO), CFO Cecilia Vidart (joined 2010), Country Manager Brazil Joyce Marinho (founding member of acquired Medicamenta), and Country Manager Chile Alejandro Bisquertt Zavala.

Latinaba generates revenue through professional services contracts on a quote-based pricing model tailored to individual study scope, phase, and geographic coverage. The company distributes services via direct enterprise field sales targeting pharma and biotech sponsors, supported by a US-based business development office and a LinkedIn corporate presence. The 2013 acquisition of Brazilian CRO Medicamenta established Brazil operations, and in January 2025 Latinaba entered a strategic partnership with Belgian CRO P95 BV to enhance vaccine and infectious disease trial capabilities and extend geographic reach across Latin America.

Latinaba firmographics

Firmographics
Name
Latinaba
Legal name
LatinaBA
Website
https://latinaba.com
Company type
Private
Founded year
2009
Operating status
Operating
Headcount range
11–50 employees
Short description
Latinaba is a private Contract Research Organization founded in 2009 that provides clinical trial services—including site management, regulatory affairs, monitoring, and medical writing—to pharmaceutical and biotech sponsors across 15 Latin American countries.
Ownership category
akta.pro rank

Latinaba industry classification

Industry
Product category
Contract Research Organization Services
NAICS
Research and Development in the Physical, Engineering, and Life Sciences (54171)
SIC
Services-Commercial Physical & Biological Research (8731)
akta.pro industry
PRIMARYHLAGAAAA
Clinical CROs (Phase I–IV)
SECONDARYHLAGACAE
Clinical Trial Site Operations & Study Coordination
SECONDARYHLAGAAAG
Medical Writing & Regulatory Submission Support CROs

Keywords

  • Contract research organization
  • Clinical trial services
  • Clinical research operations
  • Regulatory affairs services
  • Real world evidence research

Where Latinaba is headquartered

Location

Headquarters

HQ city
Coral Gables
HQ country
United States
HQ region
North America

Offices4 records

Markets served

Latinaba business model

Business model
GTM type
B2B
Offering type
Services
Cost components
Personnel, Operations, Marketing or Sales, Technology or R&D, Infrastructure

Revenue model

  1. Clinical Research Services: Latinaba generates revenue by providing contract clinical research services to pharmaceutical and biotech sponsors. Services include clinical operations, project management, regulatory affairs, site identification, monitoring, safety surveillance, medical writing, and trial oversight across all phases of clinical development.

Go-to-market motion1 record

Distribution channels1 record

Marketing channels1 record

Latinaba product offering

Product offering

Core offering

Latinaba is a regional Contract Research Organization (CRO) that provides contract clinical research services to pharmaceutical and biotech sponsors conducting trials in Latin America. Its offerings span clinical operations and project management, site identification, regulatory affairs, monitoring, safety surveillance, medical writing, real-world evidence studies, MSL services, and trial oversight, covering Phase I-IV studies and pharmacokinetics across 15 countries.

Product overview

Latinaba is a regional Contract Research Organization (CRO) offering a unified suite of clinical research services for pharmaceutical and biotech sponsors conducting trials in Latin America. The company operates through an integrated platform of service modules that span the full clinical development lifecycle: Clinical Operations & Project Management, Regulatory Affairs, Medical Devices Research, Real World Evidence (RWE) Studies, Medical Scientific Services, MSL Services, Clinical Trial Oversight, Resourcing Services, CRO and Sponsor Oversight, Quality Programs & Dedicated Services, and Consulting. With over 16 years of market experience and offices in Argentina (headquarters), Brazil, and Chile, Latinaba delivers end-to-end clinical trial execution across Phase I to IV studies. The company has completed 135 projects across 15 countries and 93 different sponsors, with expertise spanning 35 therapeutic areas including vaccines, infectious diseases, oncology, cardiovascular, and rare diseases. Recently, Latinaba entered a strategic partnership with P95 BV to enhance vaccine research capabilities in the region.

Differentiator

Problem solved

Functional benefit

Products and services

  • Clinical Operations & Project Management
  • Regulatory Affairs
  • Medical Devices Research
  • Real World Evidence
  • Medical Scientific Services
  • MSL Services
  • Clinical Trial Oversight
  • Resourcing Services
  • CRO and Sponsor Oversight
  • Quality Programs & Dedicated Services
  • Consulting

Quantifiable outcome

  • 135 completed projects delivered successfully
  • +2 more outcomes

Companies that use Latinaba

Customer profile

Segments1 record

Ideal customer profiles1 record

Latinaba technology and API

Technology

Technology focussed No

API detail

Has API
No
API docs
API detail

Core technology

AI maturity

App detail

Latinaba partnerships and signals

Strategic signal

Partnerships

One partnership is on record.

  • P95 BVcoreStrategic or Co-development Partner · 29 January 2025P95 BV, a Belgian full-service CRO specializing in vaccine development and infectious diseases, has entered a strategic partnership with LatinaBA. The collaboration combines both organizations' strengths to enhance the execution of clinical and epidemiological trials across Latin America, extending their reach to additional countries. Both companies' CEOs highlighted the complementary expertise that will enable better service to vaccine manufacturers and expanded treatment options for patients in Latin America.

Scale indicators5 records

Recent moves5 records

Expansion highlights4 records

Latinaba competitors and assessment

Company assessment

Direct peers

  • Worldwide Clinical Trials: Mid-sized global CRO with therapeutic-area specialization and central lab capabilities; comparable in scale and service scope to LatinaBA and a competitor for mid-sized LATAM clinical studies.
  • P95 BV: Belgian full-service CRO specializing in vaccine development and infectious diseases; signed a strategic alliance with LatinaBA in January 2025 to jointly deliver vaccine and epidemiological trials in Latin America — direct peer in clinical trial execution for vaccine sponsors.
  • Medpace Holdings: Mid-sized global full-service CRO with strong therapeutic-area depth across Phase I–IV studies; comparable to LatinaBA's full-service clinical operations model, though at vastly greater scale and geographic reach.
  • Syneos Health: Biopharma solutions organization offering clinical and commercial services globally, including LATAM; comparable full-service clinical operations model across multiple therapeutic areas.

Regional players

  • GEMATEC (Argentina): Regional Argentine CRO providing clinical trial management services in Latin America; closely comparable to LatinaBA as a domestic LATAM regional player competing for the same sponsor mandates.

Broad incumbents

  • Charles River Laboratories: Provides preclinical and clinical CRO services globally; competes with LatinaBA in the early-phase and clinical research services market and has established LATAM client relationships.
  • IQVIA: Largest global CRO with significant LATAM presence, real-world evidence, and technology-enabled trial services; competes head-to-head with LatinaBA for multinational and regional pharma sponsors seeking LATAM execution.
  • ICON plc: Global CRO providing clinical research, laboratory, and post-approval services; competes with LatinaBA for LATAM clinical trial work and offers overlapping therapeutic-area coverage and regulatory expertise at a larger scale.
  • PPD (Thermo Fisher Scientific): Global CRO acquired by Thermo Fisher in 2021; provides comprehensive clinical development and laboratory services with established LATAM capabilities, directly competing with LatinaBA for regional trial mandates.
  • Parexel International: Global CRO offering Phase I–IV clinical services, regulatory consulting, and post-approval evidence; directly competes with LatinaBA on LATAM-based clinical trial execution and biopharma sponsor RFPs.

Market position

Strengths4 records

Weaknesses4 records

Competitive moat4 records

Key risks6 records

Key highlights7 records

Customer concentration

Latinaba social profiles

Digital presence

Latinaba compliance and trust

Trust signal

Compliance1 record

Latinaba financial estimates

Financial estimate

Revenue estimate

Valuation estimate

Latinaba leadership team

Management profile

Number of profiles

Profiles4 records

Latinaba subsidiaries and ownership

Company hierarchy

Subsidiaries1 record

Latinaba funding detail

Funding detail

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

Latinaba M&A and investment

M&A and investment

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Latinaba

What does Latinaba do?

Latinaba is a regional Contract Research Organization (CRO) that provides contract clinical research services to pharmaceutical and biotech sponsors conducting trials in Latin America. Its offerings span clinical operations and project management, site identification, regulatory affairs, monitoring, safety surveillance, medical writing, real-world evidence studies, MSL services, and trial oversight, covering Phase I-IV studies and pharmacokinetics across 15 countries.

Is Latinaba a public or private company?

Latinaba is a private company. It is classified as founder individual operated bootstrapped and is currently operating.

When was Latinaba founded?

Latinaba was founded in 2009. It employs 11 to 50 people.

Where is Latinaba based?

Latinaba is headquartered in Coral Gables, United States, in the North America region.

How does Latinaba make money?

One revenue line is on record: clinical Research Services.

Who are Latinaba's main competitors?

Direct peers on record are Worldwide Clinical Trials, P95 BV, Medpace Holdings and Syneos Health. GEMATEC (Argentina) is listed as a regional player. Broad incumbents are Charles River Laboratories, IQVIA, ICON plc, PPD (Thermo Fisher Scientific) and Parexel International.

Does Latinaba have an API?

No public API is recorded for Latinaba.

What industry is Latinaba in?

Latinaba's product category is Contract Research Organization Services. Its primary akta.pro industry code is HLAGAAAA, Clinical CROs (Phase I–IV), with a secondary code of HLAGACAE, Clinical Trial Site Operations & Study Coordination. Its NAICS code is 54171 and its SIC code is 8731.

Unlock the full company data

50 free credits on sign-up, no credit card required.

Contact sales
Live signals